Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial
Titel:
Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial
Auteur:
Fuchs, Charles S. Özgüroğlu, Mustafa Bang, Yung-Jue Di Bartolomeo, Maria Mandala, Mario Ryu, Min-Hee Fornaro, Lorenzo Olesinski, Tomasz Caglevic, Christian Chung, Hyun C. Muro, Kei Van Cutsem, Eric Elme, Anneli Thuss-Patience, Peter Chau, Ian Ohtsu, Atsushi Bhagia, Pooja Wang, Anran Shih, Chie-Schin Shitara, Kohei